Russell Investments Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$172K Sell
9,925
-28,978
-74% -$502K ﹤0.01% 2688
2025
Q1
$851K Buy
38,903
+32,796
+537% +$717K ﹤0.01% 2101
2024
Q4
$195K Buy
6,107
+2,876
+89% +$91.8K ﹤0.01% 2545
2024
Q3
$93.2K Sell
3,231
-1,251
-28% -$36.1K ﹤0.01% 2670
2024
Q2
$172K Buy
4,482
+896
+25% +$34.4K ﹤0.01% 2518
2024
Q1
$211K Buy
3,586
+3,330
+1,301% +$196K ﹤0.01% 2431
2023
Q4
$15.3K Sell
256
-35,215
-99% -$2.11M ﹤0.01% 2781
2023
Q3
$1.35M Sell
35,471
-102,056
-74% -$3.88M ﹤0.01% 1770
2023
Q2
$12.5M Sell
137,527
-673
-0.5% -$61.3K 0.02% 664
2023
Q1
$9.12M Buy
138,200
+66,325
+92% +$4.37M 0.02% 806
2022
Q4
$3.72M Sell
71,875
-16,265
-18% -$841K 0.01% 1247
2022
Q3
$6.02M Buy
88,140
+40,082
+83% +$2.74M 0.01% 966
2022
Q2
$2.17M Buy
48,058
+309
+0.6% +$14K ﹤0.01% 1546
2022
Q1
$2.42M Sell
47,749
-60,202
-56% -$3.06M ﹤0.01% 1543
2021
Q4
$5.1M Sell
107,951
-16,483
-13% -$779K 0.01% 1239
2021
Q3
$4.1M Buy
124,434
+48,126
+63% +$1.59M 0.01% 1365
2021
Q2
$4.82M Sell
76,308
-18,663
-20% -$1.18M 0.01% 1376
2021
Q1
$4.07M Buy
94,971
+53,952
+132% +$2.31M 0.01% 1462
2020
Q4
$2.35M Sell
41,019
-51,342
-56% -$2.94M ﹤0.01% 1669
2020
Q3
$2.78M Buy
92,361
+57,940
+168% +$1.75M 0.01% 1477
2020
Q2
$1.12M Buy
34,421
+12,492
+57% +$408K ﹤0.01% 1987
2020
Q1
$587K Buy
+21,929
New +$587K ﹤0.01% 2108
2019
Q1
Sell
-57,478
Closed -$758K 2908
2018
Q4
$758K Sell
57,478
-2,936
-5% -$38.7K ﹤0.01% 2125
2018
Q3
$1.07M Buy
60,414
+10,360
+21% +$184K ﹤0.01% 2082
2018
Q2
$1.1M Hold
50,054
﹤0.01% 2075
2018
Q1
$1.11M Buy
+50,054
New +$1.11M ﹤0.01% 2168